OSE Immunotherapeutics Announces COVID-19 Prophylactic Vaccine Program
Vaccine leverages expertise in peptide selection and optimization and proprietary Memopi® technology to explore a T lymphocyte immune response for COVID-19 Uses artificial intelligence algorithm from MAbSilico to accelerate optimization of epitopes able to …